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ABSTRACT 
The case of an 82 year old lady who suffered from vivid episodic complex visual 
pseudohallucination is presented. The alleviation of symptoms with carbamazepine monotherapy is 
highlighted. Correction of visual defect as another aspect of the management of Charles Bonnet 
syndrome in elderly patients is recommended. 
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INTRODUCTION 
Charles Bonnet Syndrome is the eponym given 
to vivid complex, monomodal visual 
pseudohallucination occuring usually in elderly 
individuals in the absence of psychosis and cogni-
tive impairment. Usually the visual experiences 
are vivid, episodic and picturesque with the suf-
ferer having full insight into its unreality (Adams 
& Victor, 1903). Victor and Adams (1993) de-
scribed the syndrome of Bonnet as opthalmopathic 
hallucination occuring in patients with partial or 
full visual sensory defect or deprivation. 
CASE REPORT 
An 82 year old housewife, mother of five 
children, from Jakarta, who did not have any 
history of mental illness, complained of episodic 
visual hallucination of vivid scenes for a period of 
one year. She was having bilateral cataract with 
reasonably good vision in right eye (visual acuity 
left 6/60, right 6/24) and had got admitted in 
JIPMER hospital, Pondicherry for cataract sur-
gery. These visual experiences which contained 
scenes in and around her house in Jakarta, like 
the kitchen, the garden, the panoramic landscape 
around, people entering and leaving the house, 
etc, were transient. She could narrate and list the 
things she saw. From her description the patient's 
daughter could make out similarity between her 
visual experiences and the facilities available in 
her home in Jakarta. Patient was aware and 
amused that she was in JIPMER hospital, while 
having these unreal colourful and panoramic vis-
ual experiences. She added that whenever she 
wanted to have a closer look at the scenes she 
saw, it disappeared and she could not bring back 
these scenes voluntarily. There was no alteration 
of consciousness preceding, during or following 
the hallucinatory experience. There was no his-
tory suggestive of complex partial phenomena, 
other temporal lobe phenomena or episodic ab-
normal behaviour. Her psychomotor status was 
normal. Her primary mental functions were nor-
mal even during the episodes. She was cordial to 
the attending doctors. There were no neurologi-
cal soft or hard signs. There were no frontal lobe 
release signs. Pulse was 70/mt; blood pressure 
was 170/100 mmHg with no postural fall. Other 
systems were clinically normal. Her haemogram, 
blood biochemistry including liver and thyroid 
function tests were normal. Her blood Venereal 
Disease Research Laboratory test and ELISA for 
HTV antibodies were reported negative. Her elec-
troencephalogram and computerised tomography 
of the brain were normal. Neuropsychological 
tests for organicity were within normal limits. 
Her ability to narrate her history and different 
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topics was normal with regard to chronological 
sequence, logic and association. Her electrocardi-
ogram was normal. Doppler imaging revealed 
mild aortic stenosis, mild mitral regurgitation and 
both mitral leaflets were found to be prolapsing 
mildly to the left atrium; all the three cusps of the 
aortic valve showed mild thickening. 
With a diagnosis of Charies Bonnet Syndrome 
she was treated with carbamazepine 400 mgs 
daily in divided doses (100-100-200). She be-
came completely asymptomatic within two weeks. 
She underwent successful left sided cataract 
extraction and was discharged after two weeks 
on the same dose of carbamazepine. She was 
given aphakic spectacles for the left eye and 
advised to undergo cataract surgery for the right 
eye in due course. She was followed up for a 
period of four months till she went back to Jakar-
ta. She stopped medicines after another four 
months, and for a period of one year she was 
asymptomatic and functioning well. Then she fell 
down and sustained a fracture neck of femur and 
a 3 cm cut injury to the left side of the forehead. 
Her relatives brought her back to JIPMER hospi-
tal where she was admitted for Austin-Moore 
hemi-arthroplasty for Garden Type II fracture 
neck of femur. Detailed clinical, laboratory, and 
radiological investigations repeated in the same 
way as before were normal. Vision in right eye 
had deteriorated to 5/60. She withstood the surgi-
cal procedure well. During the post operative 
period she had the same episodic visual experi-
ences. Her mental status and repeat 
psychodiagnostic evalution were normal. She was 
put back on carbamazepine 400mg daily with 
which she became asymptomatic within two 
weeks. Her orthopedic status was satisfactory at 
the time of discharge. She was advised to contin-
ue carbamazepine and regular physiotherapy. 
DISCUSSION 
Ribeiro et al (1989) reported a case of Charles 
Bonnet Syndrome associated with blindness due 
to bilateral eye disease and a posterior parasagittal 
meningioma. These authors were of the view that 
apart from the visual defect, a 'cerebral factor" is 
operative if hallucination is to occur. They high-
lighted the fact that one should not put the blame 
on obvious eye or visual pathways affection 
when facing cases of Bonnet Syndrome. These 
areas will not explain the complex array of imag-
es perceived by any given patients. These au-
thors advise that one should intensively look for 
and rule out covert intracranial disease by appro-
priate investigation. 
McNamara et al (1982) reported the case of a 
64 year old lady who had 14 years of complete 
blindness following which she developed Charles 
Bonnet Syndrome; neurosurgical removal of a 
suprasellar meningioma made the hallucination 
disappear. Suzuki et al (1992) reported a 65 year 
old male who suffered from vivid colourful com-
plex visual hallucination. He had a small infarction 
in the left tegmentum on magnetic resonance 
imaging. Nakajima (1991) reported a 50 year and 
a 70 year old patient having computerised 
tomography proved frontomedial cerebral 
infarction. Both of them suffered from complex, 
vivid, colourful visual hallucinations. One of 
Unni's (1994) patients who was only 41 year old, 
had a self limiting Charles Bonnet Syndome 
whereas the other, a 53 year old patient refused 
carbamazepine therapy and continued to be symp-
tomatic. 
When one takes up a neuropathological ap-
proach to the diseases affecting perception, one 
or the other subtle changes may be demostrable 
in the brain but it's relevance to the disorder will 
oe difficult or impossible to establish (Corsellis 
adn Janota, 1985). The present patient did not 
have any computerised tomography proved 
intracranial disease. Even then the "cerebral fac-
tor" as proposed by Ribeiro et al (1989) can be 
speculated and conceptualised in the following 
manner ; Hosty (1990) had reported that Charles 
Bonnet syndrome is more common in the elderly. 
The present patient is an 82 year old lady who 
may have age related neuronal loss. Corsellis and 
Janota (1985) are quoting Monagle and Brody 
(1955) and Henderson, Tomlinson and Gibson 
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(1980) to say that neuronal loss in inferior olivary 
areas of hind brain will be much lesser than the 
superior temporal gyrus. The same authors are 
quoted by them to point out that in the ninth 
decade of life there is approximately a 50% 
neuronal loss. The aging brain is susceptible to 
faulty circulation (Corsellis and and Janota, 1985). 
Doppler imaging studies have demonstrated 
atherosclerotic changes in different areas of die 
patient's heart. The present patient has got an 
aging brain with probably a faulty circulation, 
subtle changes not demostrated by computed 
tomography scan. The effect of general anaesthe-
sia and water and electrolyte imbalance while on 
IV fluids superadded to the aging brain and deteri-
orating vision in her right eye might have trig-
gered the visual pseudo hallucination during the 
second postoperative period. The period of 
normalcy without medication prior to her second 
hospital stay could be explained by the fact mat 
she had good vision in her left eye after the lens 
extraction. Based on the literature on Charles 
Bonnet syndrome and the present patient, the 
authors would like to highlight that a "cerebral 
factor" and an "ophthalmic factor" may be work-
ing together in an interactive way for the clinical 
production of Charles Bonnet syndrome especial-
ly in elderly patients. 
- Nakajima (1991) highlighted the possibility of 
occipital or temporal lobe involvement in clinical 
cases of complex visual hallucination. It is strik-
ing that in the majority of cases reported in elderly 
Charles Bonnet syndrome patients, temporal lobe 
or cerebral peduncle are involved. Bhatia et al 
(1992) had successfully treated their young pa-
tients suffering from Charles Bonnet syndrome 
with carbamazepine. Their report goes in favour 
of attributing temporal lobe affection as a causa-
tive factor for Charles Bonnet syndrome. The 
present patient also responded well to 
carbamazepine monotherapy. The authors would 
like to have the view that probably the causative 
"cerebral factor" in Charles Bonnet syndrome in 
die present case could be subtle affection of the 
temporal lobe. Review of literature shows that 
tegmental infarction, frontomedial infarction, 
suprasellar meningioma, or posterior parasagittal 
tumours have also produced Charles Bonnet syn-
drome. So whatever be the logical arguments 
regarding localisation of lesion in the present 
case, a generalisation cannot be done based on 
the present knowledge of the clinical entity. 
It is felt that the original concept of Charles 
Bonnet syndrome is to be broadened to accom-
modate the "ophthalmic factor" and the "cerebral 
factor". The correction of the visual defect side 
by side with the correction of the cerebral factor 
is reccommended in the management of Charles 
Bonnet syndrome in the elderly. Berrios and 
Brook (1982) have already challenged the origi-
nal concept, as the syndrome, as per their review 
of literature, has become progressively enlarged. 
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